Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

bsn medical ltd -

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

bsn medical ltd -

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

bsn medical ltd -

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

bsn medical ltd -

Amerika Serikat - Inggris - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole delayed-release capsules is indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence. triple therapy omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults. dual therapy omeprazole delayed-release capsules in combination with clarithromycin is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h . pylori in adults. among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. in patients who fail therapy,

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

bsn medical (aust) pty ltd - 58741 - microbe-binding hydrophobic dressing - sorbact? is intended for use in management of clean, contaminated, colonized or infected wounds. sorbact? binds pathogenic bacteria, such as staphylococcus aureus, streptococci, e.coli, pseudomonas, and fungi, such as candida albicans.

Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - ciprofloxacin hydrochloride usp -

Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - ciprofloxacin hydrochloride usp -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

bsn medical (aust) pty ltd - 58741 - microbe-binding hydrophobic dressing - treatment of low exuding to dry contaminated to infected wounds. sorbact? binds bacteria such as staphyloccocus aureus, streptococci, e.coli, pseudomonas and fungi, such as candida albicans.